Grand Venture 'well-poised' to gain across segments: DBS

Singapore

GRAND Venture Technology (GVT) is likely "well-poised" to gain from the positive industry outlook on all 3 of its segments, which includes the semiconductor, life sciences, and electronics and medical segments, said DBS Group Research.

The research team on Thursday (Apr 14) initiated coverage on the precision manufacturing company with a "buy" call and target price of S$1.50, as it assumes revenue will grow by 25 per cent in FY2022 and 22.5 per cent in FY2023.